Steven M. Albelda

Albelda, Steven M

Steven M. Albelda is a board-certified pulmonary disease, critical care and internal medicine physician designing new strategies for mesothelioma treatment based on the rapidly evolving disciplines of molecular biology, immunotherapy and gene therapy.

  • Serves as vice chief and director of institution’s Lung Research, Pulmonary, and Critical Care Medicine units.
  • Research interest in cell and molecular biology.
  • Seeking better understanding of the microenvironment in which tumors grow and novel ways to alter it to increase the effectiveness of immunotherapy.
  • Exploring means of modifying T cells so that they can more easily attach to tumors, have greater killing power, and resist being neutralized by the tumor microenvironment.
  • Participating in clinical trials using an inserted adenovirus in the pleural space and T cells altered to attack the mesothelioma tumor target.
  • Authored or co-authored many articles in peer-reviewed journals.
  • Teaches at University of Pennsylvania Perleman School of Medicine.
  • Elected to American Society for Clinical Investigation.


  • M.D. degree from University of Pennsylvania School of Medicine.